Emerging Threats for Human Health in Poland: Pathogenic Isolates from Drug Resistant<i> Acanthamoeba</i> Keratitis Monitored in terms of Their<i> In Vitro</i> Dynamics and Temperature Adaptability

Chomicz, Lidia; Conn, David Bruce; Padzik, Marcin; Szaflik, Jacek P.; Walochnik, Julia; Zawadzki, Paweł J.; Pawłowski, Witold; Dybicz, Monika

doi:https://doi.org/10.1155/2015/231285

BioMed Research International

On this page

Abstract Introduction Materials and Methods Results Discussion Conclusions References Copyright Related Articles

Special Issue

Newly Emerging Parasitic Threats for Human Health: National and International Trends

View this Special Issue

Research Article | Open Access

Volume 2015 | Article ID 231285 | https://doi.org/10.1155/2015/231285

Emerging Threats for Human Health in Poland: Pathogenic Isolates from Drug Resistant Acanthamoeba Keratitis Monitored in terms of Their In Vitro Dynamics and Temperature Adaptability

Lidia Chomicz,¹David Bruce Conn,^2,3Marcin Padzik,¹Jacek P. Szaflik,⁴Julia Walochnik,⁵Paweł J. Zawadzki,⁶Witold Pawłowski,⁷and Monika Dybicz⁸

Academic Editor: Stefano D’Amelio

Received07 Sept 2015

Revised25 Oct 2015

Accepted27 Oct 2015

Published23 Nov 2015

Abstract

Amphizoic amoebae generate a serious human health threat due to their pathogenic potential as facultative parasites, causative agents of vision-threatening Acanthamoeba keratitis (AK). Recently, AK incidences have been reported with increasing frequency worldwide, particularly in contact lens wearers. In our study, severe cases of AK in Poland and respective pathogenic isolates were assessed at clinical, morphological, and molecular levels. Misdiagnoses and the unsuccessful treatment in other ophthalmic units delayed suitable therapy, and resistance to applied chemicals resulted in severe courses and treatment difficulties. Molecular assessment indicated that all sequenced pathogenic corneal isolates deriving from Polish patients with AK examined by us showed 98–100% homology with Acanthamoeba genotype T4, the most prevalent genotype in this human ocular infection worldwide. In vitro assays revealed that the pathogenic strains are able to grow at elevated temperature and have a wide adaptive capability. This study is our subsequent in vitro investigation on pathogenic Acanthamoeba strains of AK originating from Polish patients. Further investigations designed to foster a better understanding of the factors leading to an increase of AK observed in the past years in Poland may help to prevent or at least better cope with future cases.

1. Introduction

Amoebae belonging to the genus Acanthamoeba are ubiquitous and widely distributed in natural and man-made environments worldwide. Acanthamoeba spp. are free-living organisms existing as vegetative mononuclear trophozoites with characteristic acanthopodia and as double-walled dormant cysts, developing after the growth phase as well as under harsh conditions. The protists occur in sea, fresh, tap-water, and drinking water systems and in swimming pools, air conditioning systems, and humidifiers; they also occur in dust and soil, on fruits and vegetables, and in animal bodies. They have been recognized in the hospital environment as contaminants of surgical instruments and dental irrigation units, as well as in various human cavities and tissues, and on skin surfaces, oral cavities, paranasal sinuses, lungs, and brain [1–4]; trophozoites and cysts of Acanthamoeba also have been found by us among the microbiota of periodontal biofilms, accompanying infections with Entamoeba gingivalis in patients with systemic diseases [5].

The free-living amoebae complete their life cycles in different external environments, without entering humans or animals, and feed on microorganisms and small organic particles. However, in some circumstances, they are able to enter human bodies from different sources, colonize some organs, multiply within them, and thus exist as opportunistic parasites causing pathogenic effects. Epidemiological, serological, biochemical, and molecular investigations have shown that people may be exposed to pathogenic as well as nonpathogenic Acanthamoeba strains [3, 6]. It seems that the amoebae come into the human body relatively frequently, without pathogenic consequences, as indicated by 50–100% of the healthy population having specific antibodies [7–9]. However, Acanthamoeba spp. may be causative agents of the rare but usually fatal granulomatous amoebic encephalitis, developing in immunocompromised individuals as an opportunistic infection [4], and of the vision-threatening Acanthamoeba keratitis (AK) that occurs mainly in immune-competent persons. AK was first recognized in 1973 in a Texas rancher [10]. The eye disease symptoms include redness, photophobia, excessive tearing, severe eye pain, and significant deterioration of the visual acuity; without adequate therapy the amoebic infections may lead to blindness [3, 10–17].

The clinical symptoms of AK are nonspecific, similar to those observed in the course of other eye diseases, thus misdiagnosed as viral, fungal, or bacterial keratitis; a mixed keratitis caused by concomitant bacterial, viral, fungal, and Acanthamoeba infections is also known. This is why the diagnosis based on clinical symptoms alone is not sufficient to indicate the causative agent of human keratitis. The proper diagnosis needs laboratory identification of the specific pathogen for confirmation. Corneal scrapings are optimal materials for AK diagnosis. The microscopic visualization of amoebae in slides prepared directly from corneal scraping and by in vitro cultivation of the amoebic isolates deriving from these samples may be helpful also to verify previous misdiagnoses [3, 17, 18].

For years, Acanthamoeba isolates/strains were classified based on morphological criteria, mainly cyst size and structure: three morphological groups and 18 Acanthamoeba species were determined [3, 19, 20]. In the recent past, with the development of molecular systematics, PCR techniques and sequence analysis of the 18S rRNA gene have been used for diagnostics and for characterization of clinical and environmental Acanthamoeba isolates [4, 21–25].

At present, 19 genotypes are distinguished [17].

The treatment of AK is difficult, and often a resistance to pharmacotherapy develops, among other factors, due to an improper diagnosis leading to delayed suitable therapy. Moreover, the amoeba cysts are highly resistant to chemicals: disinfectants and antimicrobial and antiparasitic drugs; antiamoebic drugs are often efficient in high concentrations, which, however, are toxic for human cells [3, 4, 26–30]. Thus, despite therapeutic advances, the treatment of the keratitis caused by pathogenic Acanthamoeba strains continues to be difficult and is often unsuccessful.

In our earlier studies of 2011–2014 [16, 31], several pathogenic Acanthamoeba strains acquired from serious AK cases, variable in corneal symptom intensity and in the response to the instituted therapy, were assessed. The corneal strains have been classified as morphological group II and, in genotype identification carried out by us with PCR based on sequence analysis of the 18S rRNA, determined as T4 genotypes. In vitro viabilities of particular strains were monitored and compared. Results of the monitoring we analyzed in regard to the survival time of amoebae, AK course as well as therapeutic management difficulties/efficacies [16]. It has been revealed in our preliminary studies that monitoring of in vitro viability of pathogenic Acanthamoeba strains isolated from the infected eyes may be a useful tool for therapeutic prognosis.

A temperature tolerance of the amoebae, particularly growth/multiplication at high temperature, is often studied and reported, because it is considered as an indirect marker of potential pathogenicity of Acanthamoeba strains [3, 17, 32, 33]. However, apart from our preliminary investigations, no studies were undertaken with diagnosed pathogenic Acanthamoeba strains originating of AK in terms of their in vitro viability in changed temperature conditions.

In the present study, subsequent pathogenic Acanthamoeba isolates acquired by us from human Acanthamoeba keratitis cases unsuccessfully treated with antibacterial and antifungal medications and poorly responding to topical antiamoebic pharmacotherapy, assessed at clinical, morphological, and molecular levels, were in vitro monitored. The corneal isolates diagnosed as pathogenic Acanthamoeba strains were examined and compared to one another as well as to the environmental Acanthamoeba castellanii Neff strain in terms of their in vitro temperature sensibility/tolerance. Moreover, dynamics of these amoebic populations, cultivated parallel in vitro, their density, and morphophysiological status of particular developmental stages were assessed.

2. Materials and Methods

2.1. Acanthamoeba Pathogenic Corneal Strains: Isolates and Cultures

The material deriving from twenty-two patients who reported to our hospital in 2010–2014 at different times after first symptoms of keratitis appeared and who were under suspicion of Acanthamoeba infection was analyzed. The patients complained of photophobia, pain, excessive tearing, and deterioration of visual acuity. In the clinical diagnosis, noninvasive methods of slit-lamp and in vivo confocal microscopy were used. During the laboratory microbiological and parasitological diagnosis, direct microscopic examinations of corneal scraping material and in vitro cultures derived from those scrapings were performed to determine etiological agents of the eye deteriorations. Although Acanthamoeba infections were confirmed for all cases, the isolates marked as I-1 up to I-22 showed a high degree of variation.

In ten cases that were properly diagnosed early, 3 to 15 days after first AK symptoms appeared, and thus received early suitable treatment, an improvement was observed relatively quickly. As the isolates showed in vitro weak dynamics, trophozoites were dead in the culture medium after 8–10 days, no transformation into cysts was observed, and thus no material from these ten strains was kept for further in vitro investigations.

Another two isolates have originated from incidences in which AK has been diagnosed and pathogenic amoebae were isolated; however after moderate improvement, the two patients have not continued therapy and no information on treatment efficacy was available.

For these reasons, finally, ten remaining isolates acquired from the corneal material have been included in this analysis.

The patients, three men, all contact lens wearers, and seven women, six contact lens wearers, one of whom bathed in swimming pool, and one non-contact-lens wearer with a history of swimming in a lake, all 26–42 years old, had different intensities of pathogenic changes in their eyes. All of them had previously been unsuccessfully treated in other ophthalmic units with antifungal and antibacterial pharmaceutics; thus proper diagnosis was delayed ranging from 25 to 45 days after first symptoms appeared.

The initial identification of causative agents was achieved by in vivo confocal microscopy. The final diagnosis was made/confirmed by corneal scrapings examinations in the light microscope, first directly and next with enrichment during in vitro cultivation; the isolates were assessed at cytological and molecular levels.

The isolates originating from corneal samples of the AK patients, initially examined in wet-mount slides to visualize cysts or/and trophozoites of amoebae, were cultured under bacteria-free conditions for one to three years in sterile 15 mL tubes containing BSC culture medium [34] enriched with 10% calf serum, incubated at 27°C, and subcultured twice each month.

Additionally, environmental A. castellanii Neff strain, after years with serial passages in the same growth medium in the Laboratory of the Department of Medical Biology, Medical University of Warsaw, Poland, was used in this study.

2.2. Genotyping of Acanthamoeba Strains

All samples/isolates were also examined by PCR techniques for specific detection of Acanthamoeba DNA and to determine genotypes of the particular strains. Extraction of DNA from the samples was performed using commercial Sherlock AX Kit (A&A Biotechnology, Gdynia, Poland). Extraction of DNA from cultured in vitro isolates was performed using commercial Genomic Mini Kit (A&A Biotechnology) for routine genomic DNA extraction, according to the manufacturer’s instructions. Then, DNA was stored at −20°C. An Acanthamoeba-specific PCR following the protocol established by Schroeder et al. [21] amplifying a fragment of the 18S rRNA gene with the primers JDP1 (5′GGCCCAGATCGTTTACCGTGAA3′) and JDP2 (5′TCTCACAAGCTGCTAGGGAGTCA3′) was applied. PCR products were analyzed using GelDoc-IT Imaging Systems (UVP, USA) after gel electrophoresis on agarose gel (Sigma, St. Louis, Missouri) stained with Midori Green DNA stain (Nippon Genetics Europe GmbH, Germany). Cycle sequencing was performed and sequences obtained were compared with data available in GenBank using GeneStudio Pro Software (GeneStudio, Inc., Suwanee, Georgia).

2.3. In Vitro Growth of Acanthamoeba Isolates at Different Temperatures

The population dynamics of the corneal and environmental Acanthamoeba isolates cultured in vitro in the aforementioned growth medium under bacteria-free conditions at 27°C was systematically monitored in terms of developmental stage status by phase-contrast light microscopy.

For temperature assays, on the second day following subculturing, all cultures were shaken intensively and one mL samples of strains were transferred to 1.5 mL Eppendorf tubes containing culture medium. Next, the samples of the respective cultured strains were exposed to either 20°C, 37°C, or 42°C during 3–7 days following regular subculturing.

In vitro viability and dynamics of each particular strain population were then assessed and compared.

The morphophysiological changes and overall numbers of the amoebae as well as proportion of trophozoites and cysts were microscopically determined in the exponential and stationary growth phases. During exposure to changed temperature, cultures were vigorously shaken and 10 μL samples were successively taken for assessment of each isolate. The changes in overall number of amoebae and number of trophozoites and cysts were counted with the aid of a Burker hemocytometer. The ability of amoebae to multiply in vitro was examined; the ranges of four counts calculated for 1 mL of culture medium were compared for particular strains and assays. Results of the investigations were analyzed statistically (ANOVA, Student-Newman-Keuls method, ).

3. Results

The material assessed in our study was acquired from ten patients with symptoms of Acanthamoeba keratitis including redness, photophobia, severe eye pain, excessive tearing, and lid edema, as well as significant deterioration of visual acuity. Active epithelial inflammations, corneal ulcers, and characteristic ringlike stromal infiltration were detected by slit-lamp in the affected eyes (Figure 1).

Keratitis symptoms intensified in different degrees as the disease progressed.

3.1. Effects of Differential Diagnosis

AK was finally confirmed in all ten cases; however, several patients experienced significant delayed proper diagnosis. In the five cases in which patients reported late to their physicians and AK diagnosis was performed more than four weeks after the first keratitis symptoms appeared, hyperreflective objects identified presumably as Acanthamoeba cysts by in vivo confocal microscopy were revealed (Figure 2).

At the same time, in 3 of five cases, amoebic, bacterial, and fungal coinfections (P. aeruginosa, E. faecalis, and Candida sp.) were revealed in the microbiological diagnosis (Table 1).

In five remaining cases, in which the duration of symptoms prior to proper diagnosis was somewhat shorter, no cysts were visualized by in vivo confocal microscopy.

Finally, in all samples Acanthamoeba infection was confirmed by laboratory methods.

In parasitological microscopic examinations, Acanthamoeba cysts and trophozoites were found in different materials: some of them were detected immediately in wet-mount slides prepared from corneal scrapings, whereas others were detected after 2–7 days of in vitro cultivation of material deriving of these isolates (Table 1).

The results of molecular examinations of the isolates and a comparison of the obtained sequences with those available in GenBank revealed that all sequenced isolates showed 98–100% homology with isolates belonging to the T4 genotype. However, there were differences between particular strains. Respective highest sequence identities were found with strains originating from both environment sources and human ocular infections and from various countries of Europe, Asia, and America.

3.2. Treatment Difficulties

Material included in this analysis originated from AK cases that were previously unsuccessfully treated because of improper diagnosis.

Moderate or severe course of the eye disease needed prolonged therapeutic management. Eyes affected were treated with a topically applied agent, among others, a combination of chlorhexidine (0.02%) and polyhexamethylene biguanide (PHMB, 0.02%), propamidine isethionate (0.1%), and antibiotic neomycin; however the treatment was without clear clinical improvement. Moderate response or a resistance to applied chemicals was observed during the long-term pharmacotherapy; in several cases the treatment difficulties resulted in the necessity for surgical management (corneal X-linking, penetrating keratoplasty).

3.3. Monitoring of In Vitro Dynamics of Pathogenic Corneal Isolates and Their Temperature Adaptability

Successive monitoring of the clinical isolates and comparison to the environmental A. castellanii Neff strain cultivated in vitro allowed evaluation of morphophysiological features, their associated developmental stages, and changes in their population dynamics.

The living trophozoites with pseudopodia and characteristic protrusions, acanthopodia, were 12–38 μm in diameter, with a nucleus and prominent centrally placed nucleolus. Cysts, 8–24 μm in diameter, with their two cyst walls exhibited a wrinkled ectocyst and a polygonal or round-to-ovoid endocyst (Figure 3). The amoebae detected were identified and classified as belonging to Acanthamoeba castellanii morphological group II.

The comparative evaluation of monitored strains that at the beginning were cultivated in vitro at 27°C showed that numbers of live amoebae were low in the early adaptive phase and successively increased in the exponential growth phase while the amoebae multiplied and increased population density of particular Acanthamoeba strains.

The exposure of parallel cultures of strains to 20°C and 37°C from the 4th day following the subculturing caused clear changes in population dynamics, expressed in the overall number of amoeba cells.

Statistically significant differences were observed between pathogenic strains and the environmental A. castellanii Neff strain in terms of number of viable amoebae and thus in population density during the stationary growth phase.

Although numerous living trophozoites were detected in all cultures at 20°C, there was a significantly lower population density of pathogenic isolates cultured in vitro than the density of the Neff strain cultures (Table 2).

Contrary to this, the numbers of viable trophozoites in clinical isolates cultured at 37°C (this is near eye and general human body temperature, about 35°C to 37°C) were significantly higher in comparison to that found in the environmental strain. At this temperature, during the stationary growth phase, the highest numbers of amoebae were determined for I-19 pathogenic strain cultured in vitro, in range of four counts 44.0–102.2 × 10², that were in comparison to A. castellanii Neff strain that were 3.3–7.8 × 10² at the same temperature.

Comparative assessment of isolates exposed to 42°C showed differences between several strains. The pathogenic isolates indicated lower population activity than at 37°C, expressed in somewhat decreasing amoebic numbers.

However, in general, high amoebic population density was observed in all examined pathogenic strains during successive days of exposure to 42°C, while the number of amoebae significantly decreased in cultures of the environmental Neff strain.

Comparative data of the environmental and clinical Acanthamoeba strains deriving from severe cases of AK cultivated in vitro at 20°C, 27°C, 37°C, and 42°C are presented in Table 2.

4. Discussion

Recently, Acanthamoeba strains generate a serious human health threat due to their pathogenic potential as facultative parasites. In addition, the amoebae may also act as vehicles/sources/reservoirs of other organisms pathogenic for humans: fungal, protozoan, viral, and bacterial microorganisms which can survive and even multiply within the amoeba cells. For these reasons, epidemiological aspects are included in a majority of studies on severe vision-threatening Acanthamoeba keratitis. Investigations on the distribution of the virulent amoebic strains in different soil, air, and water environments have been conducted worldwide, also with the aid of molecular techniques. Potentially pathogenic strains are detected in environmental samples and reported worldwide [18, 25, 35–42].

In Poland, free-living amoebae have been isolated from waters in the vicinity of Poznań [43]. Successively, in further environmental studies on Acanthamoeba, potentially pathogenic strains have been detected in Lake Żarnowieckie, the Piaśnica River, and a canal used as a recreational resort in northern Poland; moreover, free-living amoebae have been isolated from natural water bodies including lakes, ponds, rivers, and lagoons of the West Pomeranian and Lubuskie area, in tap water of the water supply system of Szczecin city, in surface water layers, and in water with sediment in northern Poland at the area of the cities Gdańsk, Gdynia, and Sopot, as well as in swimming pools and fountains in western Poland [44–50].

At present, the approach based on genotype identification is more often applied to detect and characterize Acanthamoeba strains from environmental and clinical samples below the genus level. There is evidence that among seven genotypes detected in patients with AK about 90% of incidences are linked with the T4 genotype [3, 4, 17, 24]. In our investigations, all pathogenic strains of AK were identified as belonging to the T4 genotype. This is in accordance with the fact that this genotype is considered to be the most common cause of the vision-threatening eye disease. Our previous [16, 31] and this study are the only in that the molecular assessment was performed in diagnosed pathogenic Acanthamoeba isolates that originated from Polish patients with drug resistant Acanthamoeba keratitis. Complete results of these examinations will be reported in detail in a separate publication.

It is considered that the leading risk factor for Acanthamoeba keratitis is contact lens wear. After the first case of AK associated with contact lenses in Central Europe was reported from Germany, more incidences were recognized in different countries and an association between contact lens wear and Acanthamoeba keratitis was revealed [51, 52].

Nevertheless, occasionally Acanthamoeba corneal infections are also detected in persons not using contact lenses. A corneal epithelial injury, eye surgery, and, especially, an exposure of the eye to water or moist soil in which Acanthamoeba forms exist are considered as other important risk factors for acquiring AK [2–4, 17, 53].

Recently, the popularity of contact lens use is rising, and severe AK cases are reported with increasing frequency year after year, particularly in contact lens wearers (85% of all incidences), from various regions of the world, including Poland. Since the first incidences of AK were reported [54], further AK cases have been described in Poland [16, 31, 46, 47, 55].

All patients with keratitis symptoms from whom the corneal isolates were analyzed in our studies at the beginning were assessed to search for/confirm the etiological agent of the disease.

Lorenzo-Morales et al. [17] “the most important step in AK diagnosis is to think of it.” In many Acanthamoeba cases there is a history of misdiagnoses and improper therapy; also in the ten cases finally included in our study, some diagnostic difficulties and prolonged disease process occurred. The direct detection of etiological agents is considered as the only reliable diagnostic method for AK; simultaneously, cultivation remains the gold standard for Acanthamoeba laboratory diagnosis [17]. It is noteworthy that examiners have to be familiar with morphological characteristics of Acanthamoeba spp.

Currently, it has been shown that both environmental and clinical Acanthamoeba strains/isolates vary in their pathogenicity; they may be virulent, weakly virulent, or nonvirulent [4]. Simultaneously, the ability of Acanthamoeba to grow at high temperatures is considered to be correlated with the pathogenicity of Acanthamoeba isolates and to be a good indicator of the pathogenic potential of a given isolate. Thermal tolerance examinations and growth at high temperature are used as indirect markers of Acanthamoeba virulence/pathogenicity of some environmental samples [4, 17, 32].

Results of our earlier investigations [33] on environmental strains of Acanthamoeba in terms of their temperature tolerance showed that the amoebae may grow at 37°C, a temperature that is higher than that in which they had been cultured for many months; at the same time, the number of trophozoites of this strain was ~10% lower than at 26°C.

In general, our experimental investigations of ten pathogenic strains revealed the ability of all isolates deriving from AK cases to grow in higher temperature than 27°C at which they had been cultured for many months. The maintenance of metabolic activities was expressed in the relatively high population density that characterized all pathogenic Acanthamoeba isolates incubated in parallel at 37°C and 42°C.

It is noteworthy that cultures of the environmental Neff strain exhibited optimal growth at 20°C and weakest growth in temperatures higher than 27°C. Corneal pathogenic isolates developed well also at higher temperatures.

5. Conclusions

Acanthamoeba keratitis is a vision-threatening emerging eye disease caused by the facultative parasite Acanthamoeba, ubiquitous in human environments. The leading risk factor for the disease is contact lens wear, steadily rising in popularity; thus, AK is detected with increasing frequency worldwide, including Poland. Awareness of these risk factors and thus strict hygiene while cleaning and using contact lenses are crucial as preventive measures. The diagnostic and therapeutic difficulties, coupled with severe course of the disease in the cases analyzed in the current study, were due to unspecific clinical symptoms, misdiagnosis, and resulting delay in suitable treatment, as well as resistances to antimicrobial and antiparasitic therapy.

It was shown in our study that the ability of in vitro cultured corneal Acanthamoeba isolates to adapt to higher temperature was typical for all pathogenic isolates monitored. At the same time, the in vitro metabolic activities of these strains were also maintained at 20°C.

In our opinion, the pathogenic strains are not just thermotolerant but rather have a wide adaptive capability.

Our study is the first detailed study from Poland providing evidence of the significant role of adaptability to temperature changes as one of a complex of contributory factors allowing free-living amoebae to exist as parasites, namely, as the causative agents of AK, a serious human eye disease. Nevertheless, from which sources our AK patients acquired their infections remains uncertain, whether they came from natural or from man-made habitats. Also, which mechanisms enable particular strains to grow at a wide temperature range remains unclear, while others do not show this ability. These remaining areas need further studies if we are to understand the epidemiology of these opportunistic infections and to prevent future cases.

Conflict of Interests

The authors declare that there is no conflict of interests regarding the publication of this paper.

References

T. N. Teknos, M. D. Poulin, A. M. Laruentano, and K. K. Li, “Acanthamoeba rhinosinusitis: characterization, diagnosis, and treatment,” American Journal of Rhinology, vol. 14, no. 6, pp. 387–391, 2000.
View at: Publisher Site | Google Scholar
F. L. Schuster and G. S. Visvesvara, “Free-living amoebae as opportunistic and non-opportunistic pathogens of humans and animals,” International Journal for Parasitology, vol. 34, no. 9, pp. 1001–1027, 2004.
View at: Publisher Site | Google Scholar
N. A. Khan, Acanthamoeba: Biology and Pathogenesis, Caister Academic Press, Norfolk, UK, 2009.
N. A. Khan, Acanthamoeba: Biology and Pathogenesis, Caister Academic Press, Norfolk, UK, 2nd edition, 2015.
L. Chomicz, J. Piekarczyk, B. Starościak et al., “Comparative studies on the occurrence of protozoans, bacteria and fungi in the oral cavity of patients with systemic disorders,” Acta Parasitologica, vol. 47, no. 2, pp. 147–153, 2002.
View at: Google Scholar
J. Walochnik, A. Obwaller, E.-M. Haller-Schober, and H. Aspöck, “Anti-Acanthamoeba IgG, IgM, and IgA immunoreactivities in correlation to strain pathogenicity,” Parasitology Research, vol. 87, no. 8, pp. 651–656, 2001.
View at: Publisher Site | Google Scholar
N. Brindley, A. Matin, and N. A. Khan, “Acanthamoeba castellanii: high antibody prevalence in racially and ethnically diverse populations,” Experimental Parasitology, vol. 121, no. 3, pp. 254–256, 2009.
View at: Publisher Site | Google Scholar
H. Alizadeh, S. Apte, M.-S. H. El-Agha et al., “Tear IgA and serum IgG antibodies against Acanthamoeba in patients with Acanthamoeba keratitis,” Cornea, vol. 20, no. 6, pp. 622–627, 2001.
View at: Publisher Site | Google Scholar
C. L. Chappell, J. A. Wright, M. Coletta, and A. L. Newsome, “Standardized method of measuring Acanthamoeba antibodies in sera from healthy human subjects,” Clinical and Diagnostic Laboratory Immunology, vol. 8, no. 4, pp. 724–730, 2001.
View at: Publisher Site | Google Scholar
D. B. Jones, G. S. Visvesvara, and N. M. Robinson, “Acanthamoeba polyphaga keratitis and Acanthamoeba uveitis associated with fatal meningoencephalitis,” Transactions of the Ophthalmological Societies of the United Kingdom, vol. 95, no. 2, pp. 221–232, 1975.
View at: Google Scholar
J. Nagington, P. G. Watson, T. J. Playfair, J. Mcgill, B. Jones, and A. D. M. Steele, “Amoebic infection of the eye,” The Lancet, vol. 304, no. 7896, pp. 1537–1540, 1974.
View at: Publisher Site | Google Scholar
A. J. Martinez and G. S. Visvesvara, “Free-living, amphizoic and opportunistic amebas,” Brain Pathology, vol. 7, no. 1, pp. 583–598, 1997.
View at: Publisher Site | Google Scholar
F. Marciano-Cabral and G. Cabral, “Acanthamoeba spp. as agents of disease in humans,” Clinical Microbiology Reviews, vol. 16, no. 2, pp. 273–307, 2003.
View at: Publisher Site | Google Scholar
G. S. Visvesvara, “Amebic meningoencephalitides and keratitis: challenges in diagnosis and treatment,” Current Opinion in Infectious Diseases, vol. 23, no. 6, pp. 590–594, 2010.
View at: Publisher Site | Google Scholar
G. S. Visvesvara, “Infections with free-living amoebae,” Handbook of Clinical Neurology, vol. 114, pp. 153–168, 2013.
View at: Google Scholar
L. Chomicz, M. Padzik, J. P. Szaflik, W. L. Nahorski, T. Kryczka, and J. Szaflik, “Monitoring of in vitro dynamics of Acanthamoeba strains isolated from infected eyes as a useful tool in keratitis management,” Experimental Parasitology, vol. 145, pp. S73–S77, 2014.
View at: Publisher Site | Google Scholar
J. Lorenzo-Morales, N. A. Khan, and J. Walochnik, “An update on Acanthamoeba keratitis: diagnosis, pathogenesis and treatment,” Parasite, vol. 22, no. 10, pp. 1–20, 2015.
View at: Publisher Site | Google Scholar
A. Kilic, M. Tanyuksel, J. Sissons, S. Jayasekera, and N. A. Khan, “Isolation of Acanthamoeba isolates belonging to T2, T3, T4 and T7 genotypes from environmental samples in Ankara, Turkey,” Acta Parasitologica, vol. 49, no. 3, pp. 246–252, 2004.
View at: Google Scholar
M. Poussard and R. Pons, “Morphologies de la paroi kystique et taxonomie du genre Acanthamoeba (Protozoa, Amoebida),” Protistologica, vol. 13, pp. 557–610, 1977.
View at: Google Scholar
F. C. Page, A New Key to Fresh Water and Soil Gymnamoebae, Freshwater Biological Association Scientific Publications, Ambleside, UK, 1988.
J. M. Schroeder, G. C. Booton, J. Hay et al., “Use of subgenic 18S ribosomal DNA PCR and sequencing for genus and genotype identification of Acanthamoebae from humans with keratitis and from sewage sludge,” Journal of Clinical Microbiology, vol. 39, no. 5, pp. 1903–1911, 2001.
View at: Publisher Site | Google Scholar
N. A. Khan, E. L. Jarroll, and T. A. Paget, “Molecular and physiological differentiation between pathogenic and nonpathogenic Acanthamoeba,” Current Microbiology, vol. 45, no. 3, pp. 197–202, 2002.
View at: Publisher Site | Google Scholar
G. C. Booton, C. E. Joslin, M. Shoff, E. Y. Tu, D. J. Kelly, and P. A. Fuerst, “Genotypic identification of Acanthamoeba sp. isolates associated with an outbreak of Acanthamoeba keratitis,” Cornea, vol. 28, no. 6, pp. 673–676, 2009.
View at: Publisher Site | Google Scholar
A. Risler, B. Coupat-Goutaland, and M. Pélandakis, “Genotyping and phylogenetic analysis of Acanthamoeba isolates associated with keratitis,” Parasitology Research, vol. 112, no. 11, pp. 3807–3816, 2013.
View at: Publisher Site | Google Scholar
J. Walochnik, U. Scheikl, and E.-M. Haller-Schober, “Twenty years of Acanthamoeba diagnostics in Austria,” Journal of Eukaryotic Microbiology, vol. 62, no. 1, pp. 3–11, 2015.
View at: Publisher Site | Google Scholar
N. A. Turner, A. D. Russell, J. R. Furr, and D. Lloyd, “Emergence of resistance to biocides during differentiation of Acanthamoeba castellanii,” Journal of Antimicrobial Chemotherapy, vol. 46, no. 1, pp. 27–34, 2000.
View at: Publisher Site | Google Scholar
A. Aksozek, K. McClellan, K. Howard, J. Y. Niederkorn, and H. Alizadeh, “Resistance of Acanthamoeba castellanii cysts to physical, chemical and radiological conditions,” Journal of Parasitology, vol. 88, no. 3, pp. 621–623, 2002.
View at: Publisher Site | Google Scholar
K. Kopańska, A. Najda, J. Żebrowska et al., “Synthesis and activity of 1H-benzimidazole and 1H-benzotriazole derivatives as inhibitors of Acanthamoeba castellanii,” Bioorganic and Medicinal Chemistry, vol. 12, no. 10, pp. 2617–2624, 2004.
View at: Publisher Site | Google Scholar
L. Chomicz, J. Żebrowska, J. Piekarczyk et al., “In vitro studies on susceptibility of Acanthamoeba castellanii to selected chemical agents,” Acta Parasitologica, vol. 50, no. 1, pp. 25–31, 2005.
View at: Google Scholar
S. P. Johnston, R. Sriram, Y. Qvarnstrom et al., “Resistance of Acanthamoeba cysts to disinfection in multiple contact lens solutions,” Journal of Clinical Microbiology, vol. 47, no. 7, pp. 2040–2045, 2009.
View at: Publisher Site | Google Scholar
J. P. Szaflik, M. Padzik, L. Chomicz et al., “Przydatność diagnostyki in vitro w trudnych przypadkach Acanthamoeba keratitis, wymagających postępowania farmakoterapeutycznego i chirurgicznego,” Okulistyka, vol. 3, pp. 111–115, 2012.
View at: Google Scholar
J. Lorenzo-Morales, C. M. Martín-Navarro, A. López-Arencibia, F. Arnalich-Montiel, J. E. Piñero, and B. Valladares, “Acanthamoeba keratitis: an emerging disease gathering importance worldwide?” Trends in Parasitology, vol. 29, no. 4, pp. 181–187, 2013.
View at: Publisher Site | Google Scholar
L. Chomicz, M. Padzik, Z. Graczyk et al., “Acanthamoeba castellanii: in vitro effects of selected biological, physical and chemical factors,” Experimental Parasitology, vol. 126, no. 1, pp. 103–105, 2010.
View at: Publisher Site | Google Scholar
L. Červa and K. Novǎk, “Amoebic meningoencephalitis: sixteen fatalities,” Science, vol. 160, no. 3823, p. 92, 1968.
View at: Publisher Site | Google Scholar
A. Edagawa, A. Kimura, T. Kawabuchi-Kurata, Y. Kusuhara, and P. Karanis, “Isolation and genotyping of potentially pathogenic Acanthamoeba and Naegleria species from tap-water sources in Osaka, Japan,” Parasitology Research, vol. 105, no. 4, pp. 1109–1117, 2009.
View at: Publisher Site | Google Scholar
V. Nagyová, A. Nagy, Š. Janeček, and J. Timko, “Morphological, physiological, molecular and phylogenetic characterization of new environmental isolates of Acanthamoeba spp. from the region of Bratislava, Slovakia,” Biologia, vol. 65, no. 1, pp. 81–91, 2010.
View at: Publisher Site | Google Scholar
S. Gatti, P. Rama, S. Matuska et al., “Isolation and genotyping of Acanthamoeba strains from corneal infections in Italy,” Journal of Medical Microbiology, vol. 59, no. 11, pp. 1324–1330, 2010.
View at: Publisher Site | Google Scholar
A. C. M. Magliano, F. M. da Silva, M. M. G. Teixeira, and S. C. Alfieri, “Genotyping, physiological features and proteolytic activities of a potentially pathogenic Acanthamoeba sp. isolated from tap water in Brazil,” Experimental Parasitology, vol. 123, no. 3, pp. 231–235, 2009.
View at: Publisher Site | Google Scholar
L. J. Stockman, C. J. Wright, G. S. Visvesvara, B. S. Fields, and M. J. Beach, “Prevalence of Acanthamoeba spp. and other free-living amoebae in household water, Ohio, USA—1990–1992,” Parasitology Research, vol. 108, no. 3, pp. 621–627, 2011.
View at: Publisher Site | Google Scholar
M. R. Mahmoudi, N. Taghipour, M. Eftekhar, A. Haghighi, and P. Karanis, “Isolation of Acanthamoeba species in surface waters of Gilan province-north of Iran,” Parasitology Research, vol. 110, no. 1, pp. 473–477, 2012.
View at: Publisher Site | Google Scholar
M. Reyes-Batlle, C. D. Todd, C. M. Martín-Navarro et al., “Isolation and characterization of Acanthamoeba strains from soil samples in Gran Canaria, Canary Islands, Spain,” Parasitology Research, vol. 113, no. 4, pp. 1383–1388, 2014.
View at: Publisher Site | Google Scholar
C. Kiss, Z. Barna, M. Vargha, and J. K. Török, “Incidence and molecular diversity of Acanthamoeba species isolated from public baths in Hungary,” Parasitology Research, vol. 113, no. 7, pp. 2551–2557, 2014.
View at: Publisher Site | Google Scholar
W. Kasprzak and T. Mazur, “Free-living amoebae isolated from waters frequented by people in the vicinity of Poznań, Poland. Experimental studies in mice on the pathogenicity of the isolates,” Zeitschrift für Tropenmedizin und Parasitologie, vol. 23, no. 4, pp. 391–398, 1972.
View at: Google Scholar
M. Befinger, P. Myjak, and H. Pietkiewicz, “Occurrence of amphizoic amoebae in Lake Żarnowieckie,” Bulletin Maritime Tropical Medicine, vol. 37, no. 3-4, pp. 275–286, 1986.
View at: Google Scholar
K. Górnik and W. Kuźna-Grygiel, “Presence of virulent strains of amphizoic amoebae in swimming pools of the city of Szczecin,” Annals of Agricultural and Environmental Medicine, vol. 11, no. 2, pp. 233–236, 2004.
View at: Google Scholar
M. Wesołowska, A. Cisowska, P. Myjak, J. Marek, J. Jurowska-Liput, and J. Jakubaszko, “Acanthamoeba keratitis in contact lens wearers in Poland,” Advances in Clinical and Experimental Medicine, vol. 15, no. 3, pp. 553–555, 2006.
View at: Google Scholar
N. Łanocha, D. Kosik-Bogacka, A. Maciejewska, M. Sawczuk, A. Wilk, and W. Kuźna-Grygiel, “The occurrence Acanthamoeba (free living amoeba) in environmental and respiratory samples in Poland,” Acta Protozoologica, vol. 48, no. 3, pp. 271–279, 2009.
View at: Google Scholar
A. Lass, B. Szostakowska, A. Idzińska, and L. Chomicz, “The first genotype determination of Acanthamoeba potential threat to human health, isolated from natural water reservoirs in Poland,” Parasitology Research, vol. 113, no. 7, pp. 2693–2699, 2014.
View at: Publisher Site | Google Scholar
M. Adamska, A. Leonska-Duniec, N. Lanocha, and B. Skotarczak, “Thermophilic potentially pathogenic amoebae isolated from natural water bodies in Poland and their molecular characterization,” Acta Parasitologica, vol. 59, no. 3, pp. 433–441, 2014.
View at: Publisher Site | Google Scholar
M. Derda, A. Wojtkowiak-Giera, and E. Hadaś, “Comparative analyses of different genetic markers for the detection of Acanthamoeba spp. isolates,” Acta Parasitologica, vol. 59, no. 3, pp. 472–477, 2014.
View at: Publisher Site | Google Scholar
H. Witschel, R. Sundmacher, and H. M. Seitz, “Amebic keratitis: clinico-histopathologic case report,” Klinische Monatsblätter für Augenheilkunde, vol. 185, pp. 46–49, 1984.
View at: Google Scholar
M. B. Moore, J. P. McCulley, M. Luckenbach et al., “Acanthamoeba keratitis associated with soft contact lenses,” American Journal of Ophthalmology, vol. 100, no. 3, pp. 396–403, 1985.
View at: Publisher Site | Google Scholar
F. L. Schuster, “Cultivation of pathogenic and opportunistic free-living amebas,” Clinical Microbiology Reviews, vol. 15, no. 3, pp. 342–354, 2002.
View at: Publisher Site | Google Scholar
R. Gieryng, M. Prost, H. Gieryng et al., “Acanthamoeba keratitis: report of case in Poland,” in Proceedings of the 17th Congress of the Polish Parasitological Society, Abstracts of Communications, p. 165, Gdynia, Poland, September 1994.
View at: Google Scholar
M. Padzik, L. Chomicz, J. P. Szaflik, A. Chruścikowska, K. Perkowski, and J. Szaflik, “In vitro effects of selected contact lens care solutions on Acanthamoeba castellanii strains in Poland,” Experimental Parasitology, vol. 145, supplement, pp. S98–S101, 2014.
View at: Publisher Site | Google Scholar

Copyright

Copyright © 2015 Lidia Chomicz et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

PDF Download Citation

Download other formats

Order printed copies

Views

1943

Downloads

977

Citations